New Journal of Chemistry,
Год журнала:
2024,
Номер
unknown
Опубликована: Янв. 1, 2024
Hydrogel
films
were
prepared
using
mucoadhesive
extracts
from
fenugreek
and
flax
seeds,
their
versatility
for
a
range
of
biological
uses
–
such
as
anti-inflammatory,
anti-diabetic,
anti-oxidant,
anti-microbial
applications
was
examined.
Gels,
Год журнала:
2025,
Номер
11(3), С. 207 - 207
Опубликована: Март 15, 2025
Hydrogels
are
innovative
materials
characterized
by
a
water-swollen,
crosslinked
polymeric
network
capable
of
retaining
substantial
amounts
water
while
maintaining
structural
integrity.
Their
unique
ability
to
swell
or
contract
in
response
environmental
stimuli
makes
them
integral
biomedical
applications,
including
drug
delivery,
tissue
engineering,
and
wound
healing.
Among
these,
“smart”
hydrogels,
sensitive
such
as
pH,
temperature,
light,
showcase
reversible
transitions
between
liquid
semi-solid
states.
Thermoresponsive
exemplified
poly(N-isopropylacrylamide)
(PNIPAM),
particularly
notable
for
their
sensitivity
temperature
changes,
transitioning
near
lower
critical
solution
(LCST)
approximately
32
°C
water.
Structurally,
PNIPAM-based
hydrogels
(PNIPAM-HYDs)
chemically
versatile,
allowing
modifications
that
enhance
biocompatibility
functional
adaptability.
These
properties
enable
application
diverse
therapeutic
areas
cancer
therapy,
phototherapy,
healing,
engineering.
In
this
review,
the
behavior
smart
PNIPAM
explored,
with
an
emphasis
on
synthesis
methods
brief
note
biocompatibility.
Furthermore,
PNIPAM-HYDs
detailed,
along
applications
skin
conditions,
ocular
diseases,
etc.
Various
delivery
routes
patents
highlighting
advancements
also
examined.
Finally,
future
prospects
remain
promising,
ongoing
research
focused
enhancing
stability,
responsiveness,
clinical
applicability.
continued
development
is
expected
revolutionize
technologies,
paving
way
more
efficient
targeted
solutions.
European Journal of Medicinal Chemistry,
Год журнала:
2025,
Номер
290, С. 117535 - 117535
Опубликована: Март 20, 2025
Cancer
drug
delivery
remains
a
critical
challenge
with
systemic
toxicity,
poor
bioavailability,
and
lack
of
effective
targeting.
Overcoming
these
barriers
is
essential
for
improving
treatment
efficacy
patient
outcomes.
This
review
discusses
current
techniques
that
reshape
cancer
therapy
by
offering
precise,
controlled-release
tailored
to
tumor-specific
features.
Innovations
in
nanotechnology,
immunotherapy,
gene
enable
interventions
at
molecular
cellular
levels.
Radiomics
pathomics
integrate
high-dimensional
data
optimize
diagnostics
planning.
Combination
addresses
the
complexities
tumor
heterogeneity
synergizing
multiple
agents
within
single
therapeutic
framework,
while
peptide-drug
conjugates
enhance
specificity
potency.
Hydrogel-based
systems
microneedle
arrays
offer
localized,
sustained
release,
significantly
However,
clinical
translation
advancements
faces
significant
such
as
resistance,
off-target
effects,
scalability,
cost,
ethical
concerns.
Moreover,
regulatory
economic
feasibility
therapies
highlight
need
innovative
frameworks
make
them
accessible
globally.
Therefore,
there
innovation
cell
therapy,
next-generation
platforms,
personalized
medicine.
focuses
on
recent
over
past
decade,
evaluating
their
limitations
exploring
potential
future
directions
transforming
treatment.
ACS Applied Bio Materials,
Год журнала:
2025,
Номер
unknown
Опубликована: Апрель 7, 2025
Injectable
hydrogels
represent
a
highly
promising
approach
for
localized
drug
delivery
systems
(DDSs)
in
the
management
of
bone-related
conditions
such
as
osteoporosis,
osteonecrosis,
osteoarthritis,
osteomyelitis,
and
osteosarcoma.
Their
appeal
lies
their
biocompatibility,
adjustable
mechanical
properties,
capacity
to
respond
external
stimuli,
including
pH,
temperature,
light,
redox
potential,
ionic
strength,
enzymatic
activity.
These
features
enable
enhanced
targeted
bioactive
agents.
This
mini-review
evaluates
synthesis
injectable
well
recent
advancements
treating
range
bone
disorders,
focusing
on
mechanisms
sustained
DDSs
delivering
drugs,
nanoparticles,
growth
factors,
cells
(e.g.,
stem
cells).
Moreover,
it
highlights
clinical
studies
disease
treatment.
Additionally,
emphasizes
potential
synergy
between
hydrogel-based
point-of-care
technologies,
which
are
anticipated
play
pivotal
role
future
therapies.
have
transform
treatment
by
facilitating
precise,
sustained,
minimally
invasive
therapeutic
delivery.
Nevertheless,
significant
challenges,
long-term
scalability,
reproducibility,
precise
regulation
release
kinetics,
must
be
addressed
unlock
fully.
Addressing
these
challenges
will
not
only
advance
therapy
but
also
open
new
avenues
regenerative
medicine
personalized
healthcare.
Phenylboronic
acid
(PBA)
is
a
widely
exploited
glucose-sensitive
element
for
constructing
glucose-responsive
hydrogels
to
enable
smart
insulin
delivery.
Journal of Macromolecular Science Part A,
Год журнала:
2024,
Номер
61(7), С. 493 - 502
Опубликована: Июнь 3, 2024
The
work
aims
to
develop
a
biopolymer-dextrin-based
three-dimensional
crosslinked
hydrophilic
material
for
antimicrobial
delivery.
copolymer
(Dxt-PNVA)
has
been
prepared
by
in-situ
grafting
of
poly(N-vinylacetamide),
followed
cross-linking
with
N,N'-methylenebisacrylamide
dextrin.
By
varying
the
concentrations
reactants,
an
optimized
(Dxt-PNVA
5)
lowest
%
crosslinking
chosen
biomedical
applications.
copolymeric
gel
characterized
in
detail
using
various
techniques,
its
cytocompatibility
study
HeLa
Cell
lines
that
confirm
cytocompatible
nature
material.
Copolymeric
is
suitable
effective
release
two
antimicrobials
(amoxicillin
trihydrate
and
ornidazole)
from
tablet
formulation
prolonged
period
24
h.
obtained
data
demonstrates
hydrogel
potential
characteristics
daily
dose
administration
amoxicillin
ornidazole.
Nanoscale,
Год журнала:
2024,
Номер
16(28), С. 13613 - 13626
Опубликована: Янв. 1, 2024
Over
the
past
several
years,
a
significant
increase
in
expanding
field
of
biomaterial
sciences
has
been
observed
due
to
development
biocompatible
materials
based
on
peptide
derivatives
that
have
intrinsic
therapeutic
potential.